Chang Hong

机构：Shandong University, Chinese Academy of Sciences, Guangzhou Sport University, Institute of Computing Technology, Nanfang Hospital, Shandong Provincial Hospital, Southern Medical University, Dalian Polytechnic University · ORCID：0000-0001-5467-7226

发表论文 61 篇 · 总被引 603 次 · h-index 15

代表论文

• Lower creatinine to cystatin C ratio is associated with an increased risk of MASLD: A cross‐sectional and prospective study of 368,634 UK Biobank participants (2023 · Clinical Endocrinology · 被引 40)
• Splenomegaly in predicting the survival of patients with advanced primary liver cancer treated with immune checkpoint inhibitors (2022 · Cancer Medicine · 被引 33)
• Multimodal Machine Learning‐Based Marker Enables Early Detection and Prognosis Prediction for Hyperuricemia (2024 · Advanced Science · 被引 29)
• Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: a retrospective cohort study (2022 · BMC Cancer · 被引 29)
• R eticulocalbin 3 : A Ca 2+ homeostasis regulator that promotes esophageal squamous cell carcinoma progression and cisplatin resistance (2022 · Cancer Science · 被引 13)
• MiR-101-3p targets the PI3K-AKT signaling pathway via Birc5 to inhibit invasion, proliferation, and epithelial–mesenchymal transition in hepatocellular carcinoma (2025 · Clinical and Experimental Medicine · 被引 12)